DCB Funding Opportunity and Grants-Related Resources
DCB provides public resources related to funding opportunity announcements (FOAs) and NCI grant policies to cancer researchers.
"Getting a Grant from the NCI" Webinar
On April 21, 2022, Dr. Dan Gallahan (the Director of DCB) was joined by Drs. Joanna Watson (DCB Branch Chief), Amy Rubinstein (Review Branch Chief at the NIH Center for Scientific Review), and Shannon Hughes (DCB Deputy Director) for a special virtual session on NCI grant policies. It covered considerations for new and experienced applicants, as well as information about peer review.
Session Overview
New Grantee Workshop
DCB offers an annual workshop for new and early-stage investigators to familiarize them with the processes and standards of DCB, NCI and NIH. It is designed for DCB grantees who have received their first independent NIH grant within the last year.
It includes breakout sessions with DCB Program Directors and a seminar from an NCI-funded mid-career cancer researcher.
PDFs of the presentations from the January 2022 Workshop (posted with permission from each author; please do not use without consent):
- New Grantee Workshop 2022 Agenda
- Introduction to the NIH Grants System and Division of Cancer Biology
- NCI Budget Process
- Communicating with Your NCI Program Director: It's a Two Way Street
- Post-Award Administration
- NCI Resources for Researchers
- Funding for Training the Next Generation of Cancer Researchers
- CRCHD: Diversity Training and Cancer Health Disparities Research Opportunities
- Cancer Research & Patient Advocacy – Personal Perspectives from a Cancer Researcher, Caregiver and Patient
- Peer Review at NIH
- NCI’s Commitment to Equity, Diversity, Inclusion and anti-Harassment
- DCB/NCI Outreach Activities
Questions about the workshop should be directed to Dr. Joanna Watson.
FOA Pre-application Webinar Slides and Recordings
FOA Title | FOA Number(s) | Webinar Date | Webinar Materials |
---|---|---|---|
Translational and Basic Science Research in Early Lesions (TBEL) Program (U54 & U24 Clinical Trial Not Allowed) |
09/21/2021 | webinar slides | |
Acquired Resistance to Therapy Network (ARTNet) (U54 & U24 Clinical Trial Not Allowed) | RFA-CA-21-052 & RFA-CA-21-053 | 09/20/2021 | webinar slides |
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) | RFA-CA-21-049 | 09/13/2021 | webinar slides and recording |
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) | RFA-CA-21-048 | 09/13/2021 | webinar slides and recording |
PDAC Stromal Reprogramming Consortium (PSRC) (U01 & U24 Clinical Trial Not Allowed) |
08/31/2021 & 09/03/2021 |
webinar slides | |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
PAR-19-113 | 09/13/2016 | webinar slides |